Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials
…, C Hamm, J ten Berg, L Bolognese, F Saia… - European Heart …, 2010 - academic.oup.com
Aims To perform a thorough and updated systematic review of randomized clinical trials
comparing tirofiban vs. placebo or vs. abciximab. Methods and results We searched for …
comparing tirofiban vs. placebo or vs. abciximab. Methods and results We searched for …
Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam …
Objectives: This study evaluated the early outcomes of patients with acute coronary
syndromes (ACS) treated with sirolimus-eluting stents (SES). Background: The safety of SES …
syndromes (ACS) treated with sirolimus-eluting stents (SES). Background: The safety of SES …
A multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2
…, U Limbruno, A Menozzi, UOA Marchese, F Saia… - Cardiovascular …, 2018 - jacc.org
Perioperative management of antithrombotic therapy in patients treated with coronary stents
undergoing surgery remains poorly defined. Importantly, surgery represents a common …
undergoing surgery remains poorly defined. Importantly, surgery represents a common …
Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World” The R apamycin-E luting S tent E valuated …
PA Lemos, PW Serruys, RT van Domburg, F Saia… - Circulation, 2004 - Am Heart Assoc
Background—The effectiveness of sirolimus-eluting stents in unselected patients treated in
the daily practice is currently unknown. Methods and Results—Sirolimus-eluting stent …
the daily practice is currently unknown. Methods and Results—Sirolimus-eluting stent …
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies
…, LO Jensen, SJ Park, R Perry, M Racz, F Saia… - Circulation, 2009 - Am Heart Assoc
Background—The safety and efficacy of drug-eluting stents (DES) among more generalized
“real-world” patients than those enrolled in pivotal randomized controlled trials (RCTs) are …
“real-world” patients than those enrolled in pivotal randomized controlled trials (RCTs) are …
Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris
NR Mollet, F Cademartiri, K Nieman, F Saia… - Journal of the American …, 2004 - jacc.org
Objectives: This study was designed to prospectively evaluate the diagnostic performance of
multislice spiral computed tomography (MSCT) coronary angiography for the detection of …
multislice spiral computed tomography (MSCT) coronary angiography for the detection of …
Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system
…, F Ettori, A Poli, N Brambilla, F Saia… - Circulation …, 2010 - Am Heart Assoc
Background—Transcatheter aortic valve implantation (TAVI) is a new option for patients with
severe aortic stenosis at high surgical risk. The standard retrograde approach through the …
severe aortic stenosis at high surgical risk. The standard retrograde approach through the …
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the …
…, A Hoye, D Goedhart, CA Arampatzis, F Saia… - Circulation, 2004 - Am Heart Assoc
Background—The factors associated with the occurrence of restenosis after sirolimus-
eluting stent (SES) implantation in complex cases are currently unknown. Methods and …
eluting stent (SES) implantation in complex cases are currently unknown. Methods and …
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year …
…, ML Stochino, P Mazzarotto, A Cremonesi, F Saia… - The Lancet, 2018 - thelancet.com
Summary Background The Minimizing Adverse Haemorrhagic Events by Transradial Access
Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess …
Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess …
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases
PA Lemos, F Saia, JMR Ligthart, CA Arampatzis… - Circulation, 2003 - Am Heart Assoc
Background—We describe the clinical and morphological patterns of restenosis after
sirolimus-eluting stent (SES) implantation. Methods and Results—From 121 patients with …
sirolimus-eluting stent (SES) implantation. Methods and Results—From 121 patients with …